Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.
February 27 is Anosmia Awareness Day. Anosmia, which can refer to partial or full loss of smell, is a symptom in up to 90% of people with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) and is one of the symptoms most associated with decreased quality of life, according to those who experience it.1,2 Even with treatment, altered sense of smell is one of the most recalcitrant symptoms of CRSwNP.2
Learn more about altered sense of smell in CRSwNP and type 2 inflammation, which is associated with disease pathology in up to 87% of people with CRSwNP, by exploring the resources available at ADVENTprogram.com.3
1. Fokkens WJ, et al. Rhinology. 2020;Suppl. 29:1-464. 2. Mullol J, et al. J Allergy Clin Immunol Pract. 2022;10(4):1086-1095.e5. 3. Stevens WW, et al. J Allergy Clin Immunol Pract. 2019;7(8):2812-2820.e3.